H Kovari

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. pmc Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
    BMC Infect Dis 13:603. 2013
  2. pmc Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland
    Clin Infect Dis 56:870-9. 2013
  3. doi request reprint [Antimicrobial resistance among E. coli in urinary specimens: prevalence data from three laboratories in Zurich between 1985 and 2010]
    F Savaria
    Klinik für Infektionskrankheiten und Spitalhygiene, Universitat Zurich, Universitatsspital Zurich, Zurich
    Praxis (Bern 1994) 101:573-9. 2012
  4. doi request reprint Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study
    Helen Kovari
    Divisions of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich CH 8091, Switzerland
    Clin Infect Dis 49:626-35. 2009
  5. doi request reprint Influence of antiretroviral therapy on liver disease
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, University of Zurich, Zurich, Switzerland
    Curr Opin HIV AIDS 6:272-7. 2011
  6. doi request reprint Pulmonary toxoplasmosis, a rare but severe manifestation of a common opportunistic infection in late HIV presenters: report of two cases
    H Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
    Infection 38:141-4. 2010
  7. doi request reprint Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland
    Clin Infect Dis 50:502-11. 2010
  8. doi request reprint The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
    Viktor von Wyl
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    J Infect Dis 204:1095-103. 2011
  9. doi request reprint Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
    Clin Infect Dis 51:1314-22. 2010
  10. pmc Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study
    Jan Fehr
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    J Transl Med 9:14. 2011

Collaborators

Detail Information

Publications12

  1. pmc Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
    BMC Infect Dis 13:603. 2013
    ..Therefore, current international guidelines recommend dual therapy for gonorrhoea with ceftriaxone plus either azithromycin or doxycycline. Gonococcal susceptibility data in Switzerland are sparse...
  2. pmc Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland
    Clin Infect Dis 56:870-9. 2013
    ..Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality...
  3. doi request reprint [Antimicrobial resistance among E. coli in urinary specimens: prevalence data from three laboratories in Zurich between 1985 and 2010]
    F Savaria
    Klinik für Infektionskrankheiten und Spitalhygiene, Universitat Zurich, Universitatsspital Zurich, Zurich
    Praxis (Bern 1994) 101:573-9. 2012
    ..Nitrofurantoin and Fosfomycin are an appropriate choice. Microbiological testing is advised...
  4. doi request reprint Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study
    Helen Kovari
    Divisions of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich CH 8091, Switzerland
    Clin Infect Dis 49:626-35. 2009
    ..Postulated pathogenesis includes prolonged exposure to antiretroviral therapy, particularly didanosine...
  5. doi request reprint Influence of antiretroviral therapy on liver disease
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, University of Zurich, Zurich, Switzerland
    Curr Opin HIV AIDS 6:272-7. 2011
    ....
  6. doi request reprint Pulmonary toxoplasmosis, a rare but severe manifestation of a common opportunistic infection in late HIV presenters: report of two cases
    H Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
    Infection 38:141-4. 2010
    ..In both patients, early diagnosis and therapy led to a favourable outcome. Pulmonary toxoplasmosis should be considered in the differential diagnosis in potentially HIV-infected patients with respiratory symptoms...
  7. doi request reprint Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection
    Helen Kovari
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, Zurich, Switzerland
    Clin Infect Dis 50:502-11. 2010
    ..Chronic liver disease in human immunodeficiency virus (HIV)-infected patients is mostly caused by hepatitis virus co-infection. Other reasons for chronic alanine aminotransferase (ALT) elevation are more difficult to diagnose...
  8. doi request reprint The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
    Viktor von Wyl
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
    J Infect Dis 204:1095-103. 2011
    ..By analyzing human immunodeficiency virus type 1 (HIV-1) pol sequences from the Swiss HIV Cohort Study (SHCS), we explored whether the prevalence of non-B subtypes reflects domestic transmission or migration patterns...
  9. doi request reprint Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
    Barbara Hasse
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
    Clin Infect Dis 51:1314-22. 2010
    ..We studied the frequency, changes over time, and determinants of unprotected sex among HIV-positive persons...
  10. pmc Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study
    Jan Fehr
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Petersgraben 4, CH 4031 Basel, Switzerland
    J Transl Med 9:14. 2011
    ..The aim was to investigate whether the addition of rPRT to genotypic resistance testing (GRT) compared to GRT alone is beneficial for obtaining a virological response in heavily pre-treated HIV-infected patients...
  11. pmc High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease
    Jorg Schupbach
    University of Zurich, Institute of Medical Virology, Swiss National Center for Retroviruses, Zurich, Switzerland
    BMC Infect Dis 11:254. 2011
    ..Here, we sought to further investigate the diagnostic specificity of various Inno-Lia algorithms and to identify factors affecting it...
  12. doi request reprint Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
    Anna Haas
    Institute of Microbiology, ETH Zurich, Zurich, Switzerland
    Gut 60:1506-19. 2011
    ..The mechanisms underlying B cell hyperactivation and the specificities of the resulting hypergammaglobulinaemia are only poorly understood...